Disease
HIV
Chronic infection with the human immunodeficiency virus, managed with lifelong antiretroviral therapy; includes pre-exposure prophylaxis (PrEP) for HIV-negative at-risk individuals.
Total attributable cost
$59.5B
$53,945/patient
Drug spend
$46.2B
$41,834/patient
78% of total cost is drugs
All stages, diagnosed (2024 estimate) · US